These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 31977627)

  • 21. Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study.
    Domenech G; Kampel MA; García Guzzo ME; Novas DS; Terrasa SA; Fornari GG
    BMC Anesthesiol; 2019 Aug; 19(1):143. PubMed ID: 31390986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis.
    Kheterpal S; Vaughn MT; Dubovoy TZ; Shah NJ; Bash LD; Colquhoun DA; Shanks AM; Mathis MR; Soto RG; Bardia A; Bartels K; McCormick PJ; Schonberger RB; Saager L
    Anesthesiology; 2020 Jun; 132(6):1371-1381. PubMed ID: 32282427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children.
    Gaver RS; Brenn BR; Gartley A; Donahue BS
    Anesth Analg; 2019 Oct; 129(4):1124-1129. PubMed ID: 31584918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
    Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
    Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.
    Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P
    Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative Risk of Transfusion After Reversal of Residual Neuromuscular Block With Sugammadex Versus Neostigmine: A Retrospective Cohort Study.
    Schmidt MT; Paredes S; Rössler J; Mukhia R; Pu X; Mao G; Turan A; Ruetzler K
    Anesth Analg; 2023 Apr; 136(4):745-752. PubMed ID: 36651854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal.
    Ledowski T; Falke L; Johnston F; Gillies E; Greenaway M; De Mel A; Tiong WS; Phillips M
    Eur J Anaesthesiol; 2014 Aug; 31(8):423-9. PubMed ID: 24296853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Routine administration of neostigmine after recovery of spontaneous breathing versus neuromuscular monitor-guided administration of neostigmine in pediatric patients: a parallel, randomized, controlled study.
    Yang L; Hu N; Chang H; Yang D; Zuo Y
    Trials; 2023 Jan; 24(1):19. PubMed ID: 36611181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sugammadex Versus Neostigmine for Neuromuscular Block Reversal and Postoperative Pulmonary Complications in Patients Undergoing Resection of Lung Cancer.
    Yu Y; Wang H; Bao Q; Zhang T; Chen B; Ding J
    J Cardiothorac Vasc Anesth; 2022 Sep; 36(9):3626-3633. PubMed ID: 35662514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of sugammadex versus neostigmine on restoration of neuromuscular function in surgical patients with myasthenia gravis undergoing rocuronium-induced neuromuscular blockade: a systematic review protocol.
    Yellott E; Badeaux J; Martin J; Schiavo JH
    JBI Database System Rev Implement Rep; 2018 Oct; 16(10):1922-1928. PubMed ID: 30335038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diaphragmatic and intercostal electromyographic activity during neostigmine, sugammadex and neostigmine-sugammadex-enhanced recovery after neuromuscular blockade: A randomised controlled volunteer study.
    Cammu G; Schepens T; De Neve N; Wildemeersch D; Foubert L; Jorens PG
    Eur J Anaesthesiol; 2017 Jan; 34(1):8-15. PubMed ID: 27902641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case Report: Successful Reversal of Residual Block with Sugammadex in a Patient Not Known to Have Myasthenia Gravis.
    Kuo KC; Wong CS; Wu TJ
    Am J Case Rep; 2022 Oct; 23():e937128. PubMed ID: 36229945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electromyographic activity of the diaphragm during neostigmine or sugammadex-enhanced recovery after neuromuscular blockade with rocuronium: a randomised controlled study in healthy volunteers.
    Schepens T; Cammu G; Saldien V; De Neve N; Jorens PG; Foubert L; Vercauteren M
    Eur J Anaesthesiol; 2015 Jan; 32(1):49-57. PubMed ID: 25111539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neostigmine Versus Sugammadex for Reversal of Neuromuscular Blockade and Effects on Reintubation for Respiratory Failure or Newly Initiated Noninvasive Ventilation: An Interrupted Time Series Design.
    Krause M; McWilliams SK; Bullard KJ; Mayes LM; Jameson LC; Mikulich-Gilbertson SK; Fernandez-Bustamante A; Bartels K
    Anesth Analg; 2020 Jul; 131(1):141-151. PubMed ID: 31702700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial.
    Schepens T; Janssens K; Maes S; Wildemeersch D; Vellinga J; Jorens PG; Saldien V
    BMC Anesthesiol; 2019 Oct; 19(1):187. PubMed ID: 31629404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,
    Kaufhold N; Schaller SJ; Stäuble CG; Baumüller E; Ulm K; Blobner M; Fink H
    Br J Anaesth; 2016 Feb; 116(2):233-40. PubMed ID: 26787792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and outcomes of residual neuromuscular blockade: A systematic review of observational studies.
    Raval AD; Anupindi VR; Ferrufino CP; Arper DL; Bash LD; Brull SJ
    J Clin Anesth; 2020 Nov; 66():109962. PubMed ID: 32585565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.